Nanotechnology - regulation needs to catch up
This article was originally published in Clinica
As reported in Clinica this week (clinica.co.uk, 4 November), the US government is seeking feedback from the public on a draft of its 2010 National Nanotechnology Initiative (NNI) Strategic Plan, which includes a section on the FDA's priorities for the responsible development of nanomaterials in the products it regulates.
You may also be interested in...
The company formed by ex-Edwards Lifesciences exec and Harpoon Medical founder raised $8m in Series A for universal catheter system for delivering beating heart treatments.
The UK Competition and Markets Authority has concerns over the impact on the market for ankle replacements that would result from Stryker's planned $4bn acquisition of Wright Medical.
Chembio’s stock opened down 60% the day after the FDA’s decision to revoke its EUA for the first US rapid test for antibodies to SARS-CoV-2.